Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 79,600 shares, an increase of 907.6% from the April 30th total of 7,900 shares. Based on an average daily trading volume, of 90,300 shares, the days-to-cover […]
Maxim Group reiterated their hold rating on shares of Virpax Pharmaceuticals (NASDAQ:VRPX – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. Virpax Pharmaceuticals Price Performance Shares of VRPX opened at $0.72 on Wednesday. The business’s 50 day simple moving average is $2.96 and its 200-day simple moving average is […]
Shares of Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Free Report) are going to reverse split before the market opens on Friday, March 1st. The 1-10 reverse split was announced on Friday, March 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, March 1st. Virpax Pharmaceuticals Price Performance Shares […]
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 51,500 shares, a decrease of 44.1% from the December 31st total of 92,100 shares. Currently, 0.6% of the company’s stock are sold short. Based on an […]
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 47,900 shares, a growth of 197.5% from the September 15th total of 16,100 shares. Based on an average daily volume of 20,900 shares, […]